Search research articles
Contact Us
Filters
Showing results (31-40 of 147) with videos related to
Page
of 15
Sort By:
F1000Research
|
June 20, 2017
Metabolic reprogramming during the <i>Trypanosoma brucei</i> life cycle
Terry K Smith, Frédéric Bringaud, Derek P Nolan, et al.
Lipids in Health and Disease
|
September 2, 2020
Brain region-specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer's disease
Madhurima Dey, Frank J Gunn-Moore, Bettina Platt, et al.
The EMBO Journal
|
November 5, 2004
Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness
Terry K Smith, Arthur Crossman, John S Brimacombe, et al.
Parasitology
|
October 19, 2020
p67: a cryptic lysosomal hydrolase in <i>Trypanosoma brucei</i>?
Carolina M Koeller, Terry K Smith, Andrew M Gulick, et al.
Parasitology
|
November 30, 2016
The trypanosome alternative oxidase: a potential drug target?
Stefanie K Menzies, Lindsay B Tulloch, Gordon J Florence, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis
Lori Buetow, Terry K Smith, Alice Dawson, et al.
Nature Microbiology
|
October 12, 2023
Adipocyte lipolysis protects mice against Trypanosoma brucei infection
Henrique Machado, Peter Hofer, Rudolf Zechner, et al.
Plos Neglected Tropical Diseases
|
December 4, 2020
Halogenated tryptophan derivatives disrupt essential transamination mechanisms in bloodstream form Trypanosoma brucei
Peter E Cockram, Emily A Dickie, Michael P Barrett, et al.
Journal of Medicinal Chemistry
|
January 4, 2013
A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro
Linna Zhou, Gavin Stewart, Emeline Rideau, et al.
Biochemistry Research International
|
March 9, 2012
Sphingolipid and ceramide homeostasis: potential therapeutic targets
Simon A Young, John G Mina, Paul W Denny, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 147) with videos related to
Sort By:
Page
of 15
F1000Research
|
June 20, 2017
Metabolic reprogramming during the <i>Trypanosoma brucei</i> life cycle
Terry K Smith, Frédéric Bringaud, Derek P Nolan, et al.
Lipids in Health and Disease
|
September 2, 2020
Brain region-specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer's disease
Madhurima Dey, Frank J Gunn-Moore, Bettina Platt, et al.
The EMBO Journal
|
November 5, 2004
Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness
Terry K Smith, Arthur Crossman, John S Brimacombe, et al.
Parasitology
|
October 19, 2020
p67: a cryptic lysosomal hydrolase in <i>Trypanosoma brucei</i>?
Carolina M Koeller, Terry K Smith, Andrew M Gulick, et al.
Parasitology
|
November 30, 2016
The trypanosome alternative oxidase: a potential drug target?
Stefanie K Menzies, Lindsay B Tulloch, Gordon J Florence, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis
Lori Buetow, Terry K Smith, Alice Dawson, et al.
Nature Microbiology
|
October 12, 2023
Adipocyte lipolysis protects mice against Trypanosoma brucei infection
Henrique Machado, Peter Hofer, Rudolf Zechner, et al.
Plos Neglected Tropical Diseases
|
December 4, 2020
Halogenated tryptophan derivatives disrupt essential transamination mechanisms in bloodstream form Trypanosoma brucei
Peter E Cockram, Emily A Dickie, Michael P Barrett, et al.
Journal of Medicinal Chemistry
|
January 4, 2013
A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro
Linna Zhou, Gavin Stewart, Emeline Rideau, et al.
Biochemistry Research International
|
March 9, 2012
Sphingolipid and ceramide homeostasis: potential therapeutic targets
Simon A Young, John G Mina, Paul W Denny, et al.
Page
of 15